1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow corn oil control: new trials by email Literature Review of corn oil control trials Research Report on corn oil control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia Epanova® (omega-3 carboxylic acids), corn oil control - Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD) | Phase 3 | Completed | AstraZeneca | 13078 | 2014-10-30 | 2021-08-17 |
AstraZeneca (1)
Australia (1) · Belgium (1) · Canada (1) · China (1) · Czechia (1) · Denmark (1) · Estonia (1) · Hungary (1) · Italy (1) · Japan (1) · Lithuania (1) · Mexico (1) · Netherlands (1) · New Zealand (1) · Poland (1)
Michael Lincoff, MD (1) · Stephen Nicholls, MD (1) · Steven Nissen, MD (1)
2014 (1)